ACTIVE

Sealantium Medical Belgium

Financial year 2025 · Closed on 31/12/2025

Net result-7,5 k €+54,1 %over 1 year
Gross margin-7,3 k €+55,2 %over 1 year
Equity26,2 k €-22,2 %over 1 year

Identity

Source · BCE/KBO

Sealantium Medical Belgium is a Private limited company incorporated in 2024. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Diepenbeek.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 1012.599.727
Incorporation
20/08/2024
Legal form
Private limited company
Registered office
Agoralaan Abis
3590 Diepenbeek · FlandreSee on map
Contributed capital
50 000,00 €
Latest accounts
31/12/2025
Signals
Solid equityLow riskGood liquidity

Financials

Source · NBB, 2 filings

Trend over 2 financial years

20252024
Income statement
Gross margin-7,3 k €-16,3 k €
EBITDA-7,3 k €-16,3 k €
Operating result-7,3 k €-16,3 k €
Net result-7,5 k €-16,3 k €
Balance sheet
Equity26,2 k €33,7 k €
Total assets56 k €53,3 k €
Cash5 k €–
Debts29,8 k €19,6 k €
Other
Workforce–0,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active

Active mandates

Bart Van Acker

Director · since 16 janvier 2025

Active
Christopher Charles Lamb

Director · since 16 janvier 2025

Active
Sealantium Medical Ltd.

Director · since 20 août 2024 · 1010.201.253

Represented by Orgad LAUB

Active

Other companies at this address

Agoralaan Abis 3590 Diepenbeek
CompanyCBE no.
0841.685.826
BIOCLUE● Active
0719.914.105
BIOKEY● Active
0719.913.808
BIOSTRAND● Active
0719.913.907
Clinitude● Active
0478.640.857
C-Path● Active
0762.683.482
FOx Biosystems● Bankrupt
0653.744.366
0685.983.703
IDEA FAMILY● Active
0719.674.177
NanoBiotech● Active
1023.651.490
Presscuff● Active
0800.361.153
1008.398.241
SIMABS● Active
0732.709.096
1011.224.604
StingOrg● Active
0804.587.383

Full financial information

Source · NBB
20252024
Type of accountAbridged modelAbridged model
Start of the financial year01/01/202514/08/2024
Closing of the financial year31/12/202531/12/2024
Length of the financial year12 months5 months
Filing date11/06/202605/09/2025
General meeting10/06/202607/08/2025
Currency of the financial yearEUREUR
NBB quality labelSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 2 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202510/06/202611/06/2026DutchPDF
Abridged model31/12/202407/08/202505/09/2025DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active

Active mandates

Bart Van Acker

Director · since 16 janvier 2025

Active
Christopher Charles Lamb

Director · since 16 janvier 2025

Active
Sealantium Medical Ltd.

Director · since 20 août 2024 · 1010.201.253

Represented by Orgad LAUB

Active

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates24/01/2025
    Benoeming bestuurder
    PDF
  • Other22/08/2024
    OPRICHTING
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-7,5 k €↑
  2. 2024
    Annual accounts 2024-16,3 k €
  3. 20/08/2024
    IncorporationPrivate limited company